By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Neurocrine Biosciences, Inc. 

12790 El Camino Real

San Diego  California  92121  U.S.A.
Phone: 858-617-7600 Fax: 858-617-7601


SEARCH JOBS








Company News
Neurocrine Biosciences (NBIX) Announces Conference Call And Webcast To Report First Quarter 2016 Results 5/2/2016 6:55:40 AM
Neurocrine Biosciences (NBIX) To Present At The Deutsche Bank (DB) 41st Annual Health Care Conference 4/28/2016 7:19:33 AM
Neurocrine Biosciences (NBIX) To Present At The Barclays Global Healthcare Conference 3/9/2016 10:38:29 AM
Neurocrine Biosciences (NBIX) To Present At The Cowen and Company 36th Annual Health Care Conference 3/3/2016 9:05:57 AM
Neurocrine Biosciences (NBIX) Announces The Acceptance Of Three Scientific Abstracts For Valbenazine (NBI-98854) At The 68th Annual Meeting Of The American Academy of Neurology In Vancouver April 2016 3/2/2016 9:55:27 AM
Neurocrine Biosciences (NBIX) Reports Year-End 2015 Results And Provides Investor Update For 2016 2/12/2016 6:22:16 AM
Neurocrine Biosciences (NBIX) Announces Conference Call And Webcast To Report Fourth Quarter And Year-End 2015 Results 2/9/2016 6:39:22 AM
Neurocrine Biosciences (NBIX) Announces Initiation Of Phase II Clinical Study Of VMAT2 Inhibitor Valbenazine In Children And Adolescents With Tourette Syndrome 2/2/2016 6:45:00 AM
Neurocrine Biosciences (NBIX) To Present At The 34th Annual J.P. Morgan Healthcare Conference 1/5/2016 7:48:36 AM
Neurocrine Biosciences (NBIX) Announces Successful Completion Of Phase Ib T-Force Study Of VMAT2 Inhibitor NBI-98854 In Adolescents And Children With Tourette Syndrome 12/17/2015 6:35:43 AM
12345678910...
//-->